AbbVie is spearheading a new battle in pharma’s long-running fight to reform the federal government’s 340B drug discount program with a lawsuit that challenges the definition of what it means to be a ...

Winona Health is a 49-bed hospital in southeastern Minnesota. We are the definition of a community hospital in greater Minnesota — too big to be small, too small to be big. We do not have the ...

During my time as a state representative, healthcare was always a central part of the debate. I was proud to serve in the House in 2006 when Democratic legislative leadership worked with Republican ...

The federal 340B Drug Pricing Program, originally designed to maintain affordable medication access to patients who rely on safety-net clinics and hospitals, has continued to garner heightened ...

Ramachandran is an associate professor of pharmacy administration at the University of Mississippi School of Pharmacy. The 340B drug discount program requires manufacturers to sell drugs to safety-net ...

If New York legislators have questions about the efficacy of the 340B Drug Pricing Program, they should look closely at a recent 340B transparency report from the Minnesota Department of Health — a ...

Add Yahoo as a preferred source to see more of our stories on Google. If New York legislators have questions about the efficacy of the 340B Drug Pricing Program, they should look closely at a recent ...

A new report paints a stark picture of how a subset of large healthcare providers is drawing the lion’s share of 340B savings within a single state. The controversial drug discount program has been ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

340B covered entities are expanding contracts with retail pharmacies that are increasingly located in counties with high rates of Medicare and Medicaid insurance coverage. The 340B Drug Pricing ...

Only a week after calling it quits on a court-halted pilot program, the Trump administration is already revving the engine on how it could test out a rebate model for the 340B Drug Discount program.